The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Johnson & Johnson shares valued at $3,129,830 were sold by REED JOHN C on Jul 17 ’25. At $163.55 per share, REED JOHN C sold 19,137 shares. The insider’s holdings dropped to 10,658 shares worth approximately $1.83 million following the completion of this transaction.
Also, REED JOHN C purchased 19,137 shares, netting a total of over 3,129,831 in proceeds.
Before that, Decker Robert J had sold 6,999 shares from its account. In a trade valued at $1,160,994, the VP Corporate Controller traded Johnson & Johnson shares for $165.88 each. Upon closing the transaction, the insider’s holdings decreased to 6,999 shares, worth approximately $3.6 million.
As published in a research note from Erste Group on July 23, 2025, Johnson & Johnson [JNJ] has been rated up from a Hold to a Buy. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid May. Earlier on November 15, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for JNJ stock.
Analyzing JNJ Stock Performance
On last trading session, Johnson & Johnson [NYSE: JNJ] rose 0.55% to $171.53. The stock’s lowest price that day was $169.92, but it reached a high of $171.62 in the same session. During the last five days, there has been a surge of approximately 4.12%. Over the course of the year, Johnson & Johnson shares have jumped approximately 6.38%.
Is Johnson & Johnson subject to short interest?
Stocks of Johnson & Johnson saw a sharp rise in short interest on 2025-07-15 jumping by 1.94 million shares to 18.27 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 16.33 million shares. A jump of 10.63% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.21 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.21.
Which companies own the most shares of Johnson & Johnson (JNJ)?
In terms of Johnson & Johnson share price expectations, FactSet research, analysts set an average price target of 162 in the next 12 months, down nearly -5.04% from the previous closing price of $170.59. Analysts anticipate Johnson & Johnson stock to reach 162 by 2025, with the lowest price target being 162. In spite of this, 19 analysts ranked Johnson & Johnson stock as Buy at the end of 2025. On July 23, 2024, Daiwa Securities assigned a price target of “a Neutral” to the stock and downgraded coverage with a $150.
